PA
EWBC icon

PharVision Advisers’s East-West Bancorp EWBC Stock Holding History

PharVision Advisers’s Portfolio EWBC Stock Details EWBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,449
Closed -$261K – 784
2025
Q3 		$261K Buy
+2,449
New +$258K 0.15% 308
2025
Q2 		– Sell
-2,928
Closed -$263K – 322
2025
Q1 		$263K Buy
+2,928
New +$279K 0.36% 127

Other funds holding EWBC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

PharVision Advisers's EWBC Position: Q4 2025 in Review

PharVision Advisers sold out of East-West Bancorp (EWBC) in Q4 2025, closing a stake of 2,449 shares — an estimated $261K sold.

PharVision Advisers first reported a position in EWBC in Q1 2025 and held it in 2 quarters. The position peaked at $263K in Q1 2025. 583 funds tracked by Wall St. Rank hold EWBC as of Q4 2025.

  • PharVision Advisers reported no remaining East-West Bancorp position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 2,449 East-West Bancorp shares in Q4 2025, an estimated $261K.
  • PharVision Advisers first reported a position in East-West Bancorp in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's East-West Bancorp position peaked at $263K in Q1 2025.
  • 583 funds tracked by Wall St. Rank held East-West Bancorp as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.